Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma
Fares Al-Ejeh, Marina Pajic, Wei Shi, Murugan Kalimutho, Mariska Miranda, Adnan M Nagrial, Angela Chou, Andrew V Biankin, Sean M Grimmond, Michael P Brown, Kum Kum Khanna
Clinical Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2014
Awarded by Cancer Council New South Wales Innovator Grant
Awarded by Australian Research Council (ARC) Future Fellowship
Awarded by Cancer Research UK
This work was supported by the Cancer Council New South Wales Innovator Grant (IG09-04 to F. Al-Ejeh), the Justin McDonald Pancreatic Cancer grant (to F. Al-Ejeh), Australian Research Council (ARC) Future Fellowship (FT130101417 to F. Al-Ejeh), and the National Health and Medical Research Council (NHMRC) Program Grant (to K.K. Khanna).